Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Down 58.6% in July

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totaling 9,653 shares, a decline of 58.6% from the June 30th total of 23,325 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily volume of 133,939 shares, the days-to-cover ratio is presently 0.1 days.

Arcadia Biosciences Price Performance

Shares of RKDA opened at $0.64 on Monday. The firm has a 50 day simple moving average of $0.81 and a two-hundred day simple moving average of $1.38. Arcadia Biosciences has a one year low of $0.59 and a one year high of $6.71. The company has a market cap of $1.40 million, a P/E ratio of -0.11 and a beta of 0.54.

Arcadia Biosciences (NASDAQ:RKDA) last issued its earnings results on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The business had revenue of $1.10 million during the quarter, compared to analyst estimates of $1.60 million.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Arcadia Biosciences currently has an average rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.